U.S.: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in the U.S.

The U.S. market for medicaments of alkaloids or derivatives thereof expanded sharply to $X in 2021, growing by X% against the previous year. The market value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2021, consumption stood at a somewhat lower figure.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in the U.S.

In value terms, production of medicaments of alkaloids or derivatives thereof amounted to $X in 2021. The total output value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 with an increase of X%. Over the period under review, production of attained the peak level at $X in 2019; however, from 2020 to 2021, production remained at a lower figure.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from the U.S.

In 2016, after two years of growth, there was significant decline in shipments abroad of medicaments of alkaloids or derivatives thereof, when their volume decreased by -X% to X tons. In general, exports recorded a deep contraction. The most prominent rate of growth was recorded in 2015 when exports increased by X%. As a result, the exports attained the peak of X tons, and then dropped significantly in the following year.

In value terms, exports of medicaments of alkaloids or derivatives thereof dropped sharply to $X in 2016. Over the period under review, exports recorded a abrupt decrease. The pace of growth was the most pronounced in 2015 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X, and then reduced rapidly in the following year.

Exports by Country

Canada (X tons), Switzerland (X tons) and the UK (X tons) were the main destinations of exports of medicaments of alkaloids or derivatives thereof from the United States, with a combined X% share of total exports. Italy, Japan and India lagged somewhat behind, together accounting for a further X 2012 to 2016, the biggest increases were in India (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Switzerland ($X) remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from the United States, comprising X% of total exports. The second position in the ranking was held by Italy ($X), with a X% share of total exports. It was followed by the UK, with an X% share.

From 2012 to 2016, the average annual growth rate of value to Switzerland amounted to -X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (+X% per year) and the UK (+X% per year).

Export Prices by Country

In 2016, the average export price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, with a decrease of -X% against the previous year. Over the period from 2012 to 2016, it increased at an average annual rate of +X%. The pace of growth appeared the most rapid in 2013 when the average export price increased by X%. As a result, the export price reached the peak level of $X per ton. From 2014 to 2016, the the average export prices remained at a somewhat lower figure.

Prices varied noticeably country of destination: the country with the highest price was Switzerland ($X per ton), while the average price for exports to Canada ($X per ton) was amongst the lowest.

From 2012 to 2016, the most notable rate of growth in terms of prices was recorded for supplies to Switzerland (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into the U.S.

In 2016, imports of medicaments of alkaloids or derivatives thereof into the United States soared to X tons, rising by X% on 2015 figures. In general, imports, however, continue to indicate a slight descent. The most prominent rate of growth was recorded in 2015 when imports increased by X%. Imports peaked at X tons in 2012; however, from 2013 to 2016, imports stood at a somewhat lower figure.

In value terms, imports of medicaments of alkaloids or derivatives thereof reduced sharply to $X in 2016. Overall, imports, however, showed a relatively flat trend pattern. The growth pace was the most rapid in 2014 with an increase of X%. Imports peaked at $X in 2015, and then shrank rapidly in the following year.

Imports by Country

In 2016, India (X tons) constituted the largest medicaments of alkaloids or derivatives thereof supplier to the United States, accounting for a X% share of total imports. Moreover, imports of medicaments of alkaloids or derivatives thereof from India exceeded the figures recorded by the second-largest supplier, Italy (X tons), sixfold. Canada (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2016, the average annual growth rate of volume from India amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (+X% per year) and Canada (+X% per year).

In value terms, Germany ($X) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to the United States, comprising X% of total imports. The second position in the ranking was held by India ($X), with a X% share of total imports. It was followed by Italy, with a X% share.

From 2012 to 2016, the average annual rate of growth in terms of value from Germany stood at +X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (+X% per year) and Italy (+X% per year).

Import Prices by Country

In 2016, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, reducing by -X% against the previous year. Over the period under review, the import price, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2014 when the average import price increased by X%. As a result, import price reached the peak level of $X per ton. From 2015 to 2016, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2016, the country with the highest price was Germany ($X per ton), while the price for Israel ($X per ton) was amongst the lowest.

From 2012 to 2016, the most notable rate of growth in terms of prices was attained by Italy (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :